MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma

Leukemia. 2008 Aug;22(8):1646-8. doi: 10.1038/leu.2008.43. Epub 2008 Mar 6.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibody Formation*
  • Antigens, Neoplasm / immunology*
  • Base Sequence
  • Blotting, Western
  • DNA Primers
  • Humans
  • Multiple Myeloma / immunology*
  • Neoplasm Proteins / immunology*

Substances

  • Antigens, Neoplasm
  • CT7 antigen, human
  • DNA Primers
  • MAGEC1 protein, human
  • Neoplasm Proteins